"Biological Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.
| Descriptor ID |
D001688
|
| MeSH Number(s) |
D20.215
|
| Concept/Terms |
Biological Products- Biological Products
- Biologic Products
- Products, Biologic
- Biologics
- Products, Biological
|
Below are MeSH descriptors whose meaning is more general than "Biological Products".
Below are MeSH descriptors whose meaning is more specific than "Biological Products".
This graph shows the total number of publications written about "Biological Products" by people in this website by year, and whether "Biological Products" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 3 | 0 | 3 |
| 2009 | 1 | 0 | 1 |
| 2010 | 5 | 1 | 6 |
| 2011 | 3 | 0 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 1 | 3 |
| 2015 | 2 | 1 | 3 |
| 2016 | 6 | 0 | 6 |
| 2017 | 8 | 1 | 9 |
| 2018 | 4 | 2 | 6 |
| 2019 | 2 | 2 | 4 |
| 2020 | 13 | 0 | 13 |
| 2021 | 11 | 4 | 15 |
| 2022 | 6 | 1 | 7 |
| 2023 | 9 | 0 | 9 |
| 2024 | 4 | 3 | 7 |
| 2025 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biological Products" by people in Profiles.
-
Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case series. BMC Neurol. 2025 Jul 07; 25(1):283.
-
Biologics for severe asthma: deciphering what is best for the patient. Expert Rev Clin Immunol. 2025 Aug; 21(8):1035-1054.
-
Chemotype- and Target-Driven Genome Mining for a New Natural Product Inhibitor of Bacterial Peptide Deformylase. J Am Chem Soc. 2025 Jun 25; 147(25):21400-21407.
-
Association of Primary Language With Treatment and Outcomes in Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2025 Aug 01; 16(8):e00868.
-
Biologics in congenital ichthyosis: are they effective? Br J Dermatol. 2025 Jan 24; 192(2):327-334.
-
Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity. Mol Cancer. 2025 Jan 13; 24(1):12.
-
The Emerging Role of Alarmin-Targeting Biologics in the Treatment of Patients With COPD. Chest. 2025 May; 167(5):1346-1355.
-
Perioperative Implications of Biologics and Immunotherapy. Adv Anesth. 2024 Dec; 42(1):97-113.
-
Anti-stroke biologics: from recombinant proteins to stem cells and organoids. Stroke Vasc Neurol. 2024 Nov 05; 9(5):467-480.
-
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel. Blood Adv. 2024 10 22; 8(20):5346-5354.